Building QSAR Models to Guide Drug Design · PDF fileOlga Obrezanova, PhD ... Exercise 3...

© 2009 Optibrium Ltd.Optibrium™, StarDrop™, Auto-Modeler™ and Glowing Molecule™ are trademarks of Optibrium Ltd.

Building QSAR Models to Guide Drug Design

Olga Obrezanova, PhD

© 2009 Optibrium Ltd. 2

Workshop Objectives

• Building predictive models

− Automatic model building tool

• Using in silico and experimental data to make decisions

− Compound prioritisation

− Visualisation tools


Workshop Program

• Automatic model generation process

Exercise 1 – Building category model of BBB penetration

Exercise 2 – Building continuous model of ion-channel affinity

• Compound prioritisation

− Using scoring to identify compounds with a balance of properties

• Interactive redesign

− Making the link between structure and predicted property

Exercise 3 – Prioritising compounds and using predictive models for compound redesign

• Balancing diversity and quality

Exercise 4 – Chemical space: Selecting diverse compounds with a good balance of properties


Automatic Model Generation

Auto-Modeler



• Splitting data into training, validation and test sets

− cluster analysis by structural similarity at certain Tanimoto level

− Y based

− random

− manual split

• Descriptor calculation and filtering

− 2D SMARTS, logP, TPSA, charge...

− user defined SMARTS

− imported descriptor values, e.g. experimental data

Data set

trn val test



• Modelling techniques applied to training set

− Partial Least Squares (PLS)

− Radial Basis Functions with Genetic Algorithm

− Gaussian Processes

− Decision Trees (category models)

• Selection of the best model by performance on the validation set

− R², RMSE for continuous models

− Accuracy, kappa-statistic for category models

• Test set is an independent set

Data set

trn val test

Buildmodels

PLS

RBF

GPs

Bestmodel

Evaluate multiple models

Test the best model



Data set

trn val test

Buildmodels

PLS

RBF

GPs

Bestmodel

Evaluate multiple models

Test the best model

New compounds

Prediction Confidence

Estimation of uncertainty with each prediction


Modelling Techniques: Gaussian Processes

• A machine learning method based on Bayesian approach

• Advantages:

− Does not require a priori determination of model parameters

− Nonlinear relationship modelling

− Built-in tool to prevent overtraining - no need for cross-validation

− Inherent ability to select important descriptors

− Provides uncertainty estimate for each prediction

• Sufficiently robust to enable automatic model generation


Modelling Techniques: Gaussian Processes

• Define prior distribution over functions (controlled by hyperparameters, covariance function – ARD function)

• Posterior distribution: retain functions which fit experimental data

• Prediction is the mean of posterior distribution.

• Standard deviation of the distribution provides estimate of the uncertainty in prediction

f(x)

x

Functions from the prior distribution

f(x)

x

Functions from the posterior


Modelling techniques. Gaussian Processes

• Learning the Gaussian Process equivalent to finding hyperparameters

− Length scale parameters (one for each descriptor) identification of relevant descriptors

− Noise parameter

• Find hyperparameters by optimizing the marginal log-likelihood

− It controls the trade-off between the model complexity and fit to the data no need for cross-validation, prevents overfitting, does not require user intervention

Length scale =0.6

Length scale =1.2


Gaussian Processes: Hyperparameters

• Learning the Gaussian Process ~ finding hyperparameters

− Optimize the marginal log-likelihood (prevents overtraning, no need for validation set)

• Techniques for finding hyperparameters

− “Fixed” values for length scales. Search for noise parameter

− Forward variable selection provides feature selection

− Optimisation by conjugate gradient methods

o Length scales show which descriptors are most relevant

− Nested sampling

o Search in the full hyperparameter space

o Search does not get trapped in local maxima

com

pu

tati

on

al d

em

and


Gaussian Processes: Nested Sampling

• 2 variables.

• Find maximum of likelihood:

variable 1

vari

able

2


Exercise 1

Building a classification model of blood-

brain barrier penetration

Objectives

− Familiarity with StarDrop and the Auto-Modeler

− Building classification models

− Familiarity with performance measures for category models


Performance MeasuresCategory models

• Overall accuracy

• Kappa-statistic

κ= (Observed Agreement- Chance Agreement)/ (Total – Chance Agreement)

κ < 0.4 poor or fair agreement

0.4≤ κ <0.6 moderate agreement

0.6≤ κ <0.8 good agreement

0.8≤ κ <1 very good agreement

• Sensitivity and specificity in individual classes

Predicted ‘No’

Predicted ‘Yes’

Observed ‘No’

17 2

Observed ‘Yes’

1 10

Confusion matrix

For ‘No’ For ‘Yes’

Accuracy (sensitivity)

0.94 0.83

Specificity 0.89 0.91


Automatic Models Versus Manual

Experiment


Automatic Models versus Manual

• Model built ‘manually’ by computational chemists

• Model from the automatic model generation process (apply

to all compounds in a dataset)

• Compare ‘automatic’ and ‘manual’ models by testing on external data set

• Two data sets:

− Blood-brain barrier penetration (151 compounds with logBB values)

− Intrinsic aqueous solubility ( 3313 compounds with logS values from PHYSPROP database)


Blood-Brain Barrier Penetration

• ‘Manual’ model

− 2D SMARTS descriptors reduced by FVS, various modelling techniques (PLS, RBF, MLR) –performance supervised on test set

− Final model is built by RBF on 7 descriptors (logP, flexibility, charge, hydrogen bonding…)

• ‘Automatic’ model built by Gaussian Processes with nested sampling on 162 descriptors

• External set: 143 compounds from ‘Abraham’ set

− Abraham et al. J.Pharm. Sci., 2006, 95

Test set

R² 0.73

RMSE 0.36

Val+Test set

R² val 0.72

R² test 0.66

RMSE 0.44

manual

automatic


Blood-Brain Barrier Penetration Performance on external ‘Abraham’ test set

Model RMSE pred

% pred within ±0.4 log unit


R² r²corr RMSE

manual 0.36 62.9 93.0 0.39 0.44 0.44

automatic 0.44 63.6 90.9 0.27 0.36 0.49

manual automatic


Aqueous Solubility

• Manual model is built by RBF method on ~ 100 descriptors

• Automatic model is produced by Gaussian Processes with 2D search

• External test data – 564 compounds from ‘Huuskonen’ set

− Huuskonen J., J. Chem. Inf. Comput. Sci., 2002, 42

Test set

R² 0.82

RMSE 0.79

Val+Test set

R² val 0.84

R² test 0.85

RMSE 0.69

manual

automatic


Aqueous SolubilityPerformance on external ‘Huuskonen’ test set

manual automatic

Model Desc % pred within ±0.7 log unit


R² r²corr RMSE

manual 108 39.9 70.9 0.68 0.80 1.28

automatic 166 54.1 85.9 0.82 0.86 0.96

pre

dic

ted

pre

dic

ted

observed observed


Exercise 2

Building a continuous model of ion-

channel affinity

Objectives

− Building continuous models

− Familiarity with performance measures for continuous models

− Using the model to predict new compounds


Performance MeasuresContinuous models

• Root-mean-square error

• Coefficient of determination

− R² is different from Pearson’s squared correlation coefficient

− R² measures the fit around the identity line

− Pearson’s r²corr measures fit around regression line between yobs and ypred

− R² > 0.5 at least!

N

i

obs

i

pred

i yyN

RMSE1

2)(1

i

obsobs

i

i

obs

i

pred

i

yy

yy

R2

2

2

)(

)(

1

Predicted versus observed


Compound Prioritisation

Probabilistic Scoring


10,000 compounds through 8 models is80,000 data points!

Q. How do you use this data to make decisions?

Industry Challenge


Applying Data to Making Decisions

PrioritiseData Selection

Redesign

In silico In vitro In vivo

Relevance

Uncertainty

Quality

Diversity

Value created by good decisions, not data

Prioritise


Prioritisation:Dangers of Filtering Approach

Absorption

Metabolic Stability

Potency


Property Y

100 10 1 0.1

Desired value > Threshold

A B C

UNDESIRABLE DESIRABLE

Importance of Uncertainty

X X

Filtering approach

No uncertainty


Property Y

100 10 1 0.1


A B C



X X

Take into account

uncertainty!



100 10 1 0.1


D E


Property Z

Compound D has

more chances to

succeed than

compound E


StarDrop Prioritisation:Probabilistic Scoring

Integrated assessment of data against project criteria

Uniquely accounts for the uncertainties in all compound-related data (experimental or calculated)

User-defined scoring profile Compounds ranked

Histograms for quick visual guide to

compound properties


StarDrop Prioritisation:Probabilistic Scoring

• Property data

− Experimental or predicted

• Criteria for success

− Relative importance

• Uncertainties in data

− Experimental or statistical

• Score (Likelihood of Success)• Confidence in score

Sco

re

Best Worst

Error bars show confidence in overall score

Data do not separate these, as error bars overlap

Bottom 50% may be rejected with confidence


Example of a Scoring Profile

Models Desired values Importance

Aqueous solubility >10µM

Absorption (HIA) + (> 30%)BBB classification +

Log ([brain]:[blood]) >-0.5

P-gp transport non substratehERG Affinity (pIC50) <6.0

CYP2D6 affinity low or medium

CYP2C9 affinity (pKi) <6.0

Plasma protein binding low


Interactive Redesign

‘Glowing Molecule’




Redesign


Relevance

Uncertainty

Quality

Diversity


The ‘Glowing Molecule’Visualisation tool

• Makes a link between predicted property and compound’s structure

−“Why is a property value predicted?”

−“Where can I change this property?”

−Interpret SAR

−Guide efficient redesign of molecules

• No-more ‘black box’ models!

logP property


Exercise 3

Prioritising compounds and using

predictive models for compound redesign

Objectives

− Identifying and prioritising compounds with a good balance of ADME properties and the affinity

− Identifying chemical groups which have a positive influence on the affinity

− Designing a new compound with improved affinity and good balance of other properties


Balancing Diversity and Likelihood of Success

Chemical Space and Selection




Redesign


Relevance

Uncertainty

Quality

Diversity


Chemical Space

• A chemical space allows you to visualise trends across your data set

• Each point represents one compound

• The closer two points are the greater their similarity

− Structure

− Properties

− Mixed

• A space is defined by a single data set…

• …but other data sets can be plotted in that space at the same time

Drug-like space

5HT1a library

(selected subset)

Two similar compounds

This compound


Chemical Space‘Zooms’ to appropriate resolution

Space defined by diverse drug-like chemistry (black)

Space defined by virtual library (blue)

Virtual library (blue) and selection (red)


Selection:Balance Quality Against Diversity

• It may not be optimal to select only the highest ranked compounds

− Making many almost identical compounds may not be the best use of resources

• Often a small sacrifice in quality can significantly increase the diversity of compounds selected

− Spread risk across greater diversity of chemistry

− Gather additional data on SAR

• Compound selection provides ability to explore the trade-off between quality and diversity


Exercise 4

Chemical space and selection of diverse

compounds with balance of properties

Objectives

− Exploring chemical space map

− Selecting a subset of compounds with a good chance of success against the target product profile and a good coverage of chemical diversity


Conclusions

• The automatic model generation process is robust, much quicker than manual building and can be applied by non-experts. Automatic models compare well to ones built manually.

• Models can guide the design of new molecules through interpretation of SAR.

• When selecting compounds, models may be used to bias the odds of success by focussing on areas of chemistry most likely to yield a successful drug, rather than on an individual property of molecules.


Acknowledgements

• Matthew Segall

• Ed Champness

• Chris Leeding

www.optibrium.com

[email protected]

Building QSAR Models to Guide Drug Design · PDF fileOlga Obrezanova, PhD ... Exercise 3...

Documents

Transcript of Building QSAR Models to Guide Drug Design · PDF fileOlga Obrezanova, PhD ... Exercise 3...